SEC Form 4 · accession 0001144204-17-028452
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven S Myers
Director · Other
Period of report
May 16, 2017
Accepted (ET)
May 18, 2017 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 16, 2017 | A | 2,565 | $0.00 | A | 36,159 | D | |
| Common Stock | holding | — | — | — | 8,434 | I | By Steven S. Myers IRA | |
| Common Stock | holding | — | — | — | 802 | I | By Spouse | |
| Common Stock | holding | — | — | — | 1,954 | I | By Steven S. Myers Revocable Trust dated 12/1/2000 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents an award of 2,565 Restricted Stock Units granted under the Issuer's 2015 Equity Compensation Plan that will vest on May 16, 2018. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.
- F2Includes 750 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on June 22, 2017, 1,650 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018, 2,565 shares of unvested Restricted Stock Units granted under the Issuer's 2015 Equity Compensation Plan that will vest on May 16, 2018 and 312 shares of unvested restricted stock granted under the Issuer's 2009 Equity Compensation Plan that will vest quarterly through June 2, 2018.
Remarks
Interim Chairman of the Board of Directors